Government Shutdown Looms, SNAP Benefits at Risk, and Nuclear Testing Resumes
Table of Contents
The United States faces a confluence of critical challenges as a potential government shutdown threatens essential services, millions brace for the loss of food assistance, and a controversial decision to resume nuclear weapons testing raises global concerns.
As of November 1, a government shutdown is poised to impact a wide range of Americans, with approximately 42 million people potentially losing their SNAP (Supplemental Nutrition Assistance Program) food benefits. Simultaneously, enrollment for federal insurance exchanges begins Saturday, but premiums are projected to more than double on average, sparking a political battle over healthcare subsidies. Democrats have indicated a willingness to vote to reopen the government if Congress agrees to extend these subsidies to mitigate rising costs. The disruption is already being felt, as major airlines appealed to Congress on Thursday to pass a Republican stopgap funding plan amid ongoing challenges with air traffic control staffing.
Flights at Orlando International Airport experienced significant delays on October 30 after the Federal Aviation Administration reported a lack of certified air-traffic controllers in the tower. This situation underscores the immediate consequences of the shutdown, as air traffic controllers are being forced to work without pay. According to NPR’s Barbara Sprunt, Democrats appear confident that Republicans will be blamed for the shutdown, hoping public pressure will mount over the anticipated increase in health insurance premiums. “Democrats seem to think Republicans will take the blame for the shutdown and not them,” Sprunt reported. Republicans, however, maintain they are actively seeking votes to fund the government and argue that Democrats are obstructing efforts to provide nutrition aid and ensure air traffic controller salaries.
The potential cutoff of SNAP benefits is unprecedented during a government shutdown, prompting legal action. The Agriculture Department announced it had exhausted its funds and lacked the legal authority to utilize contingency funds for next month’s benefits. In response, Democratic governors and attorneys general from roughly two dozen states filed a lawsuit, asserting that SNAP is an entitlement program that cannot be arbitrarily suspended. Even if a favorable ruling is issued swiftly, NPR’s Jennifer Ludden notes that delays are inevitable. “The federal government sends funding to the states before the first of the month, and then it takes days to get it onto the debit-like cards that people use,” she explained. The situation is further complicated by a significant funding shortfall – approximately $9 billion is needed for November’s SNAP benefits, but only $5.5 billion is currently available in contingency funds, potentially leading to reduced and delayed payments.
Adding to the escalating tensions, President Trump announced on Thursday that the U.S. would resume testing nuclear weapons for the first time in decades. Experts warn this decision could significantly escalate global instability and disrupt the existing nuclear balance of power. According to NPR’s Geoff Brumfiel, major nuclear powers have maintained a testing moratorium since the 1990s as a gesture of goodwill following the Cold War. The U.S. has instead focused on scientific methods to ensure weapon functionality without actual testing, utilizing facilities in the Nevada desert. While the U.S. currently holds a technological advantage, resuming tests could allow Russia and China to close the gap, warns Jon Wolfsthal at the Federation of American Scientists. Environmental concerns also exist, as even contained underground tests could cause structural damage to nearby buildings.
Promising Developments in Alzheimer’s Research
In a separate but hopeful development, scientists are re-evaluating an experimental Alzheimer’s drug, valiltramiprosate (ALZ-801), which may offer benefits to individuals at high risk of developing the disease. Initial study results in April, involving over 300 participants aged 50 and older with a genetic predisposition to Alzheimer’s, were inconclusive. However, a subsequent analysis in September revealed potential benefits for a subgroup of 125 participants exhibiting only mild memory impairment. By one measure, the drug slowed cognitive decline by 52% in this group, though researchers caution that the small sample size limits definitive conclusions. ALZ-801 could receive expedited consideration from the Food and Drug Administration due to its potential advantages over existing treatments, including at-home administration and a reduced risk of brain swelling or bleeding. Further data is expected as participants continue taking the medication beyond the initial 18-month study period, according to co-author David Watson.
Weekend Entertainment & More
Here’s a look at what NPR is recommending for the weekend:
- Movies: Enjoy a selection of horror films released this year, ranging from supernatural thrillers to more realistic scares.
- TV: Explore “Talamasca: The Secret Order,” a series centered on a secret society investigating the supernatural elements of Anne Rice’s fictional world.
- Books: Dive into “Wreck” by Catherine Newman, a follow-up to her acclaimed novel “Sandwich.”
- Music: Get into the Halloween spirit with a curated playlist of spooky and nostalgic songs.
- Food: Elevate your meals with three flavorful sauces from Roy Choi’s cookbook, The Choi of Cooking.
- Quiz: Test your knowledge with NPR’s latest news quiz.
Three Things to Know Before You Go
- Trick-or-Treat for UNICEF is celebrating its 75th anniversary, having collected approximately $200 million for children in need worldwide.
- The interstellar comet 3I/ATLAS has entered our solar system, offering a rare opportunity for scientific observation.
- A re-examination of the “Dueling Dinosaurs” fossil reveals it is not a Tyrannosaurus rex, but a previously unknown species, Nanotyrannus lancensis.
This newsletter was edited by Obed Manuel.
